
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
AmCad BioMed Corporation, established in 2008, is a leader in the field of ultrasound AI diagnostic assessments for various clinical indications. The company was the first to receive an FDA license for ultrasound CAD solution, and has been publicly traded on the Taiwan Stock Exchange since 2015. Its products and pipeline feature the FDA cleared, CE marked and clinically validated soultions including (1) AmCAD-UT for thyroid nodules analysis, (2) AmCAD-UO for obstructive sleep apnea (OSA) detection, (3) AmCAD-US for backscattered signals analysis useful in Liver Steatosis and other diagnosis capabilities, (4) AmCAD-CA for thyroid FNA cytopathology indication, (5) and the...
Thyroid cancer detection ,obstructive sleep apnea detection,breast cancer detection,ultrasound imaging detection,deep learning,medical ai,liver steatosis ultrasound ai analysis,and compelement of ent dise accessment
Amcad biomed operates in the Medical equipment manufacturing industry.
Amcad biomed's revenue is 1m - 10m
Amcad biomed has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.